Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors
Movement Disorders Clinical Practice · 2024
DOI: 10.1002/mdc3.14003 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Alessandro Dinoto und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Movement Disorders. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Immune checkpoint inhibitors (ICI) may trigger autoimmune neurological conditions, including movement disorders (MD).
Objectives
The aim of this study was to characterize MDs occurring as immune‐related adverse events (irAEs) of ICIs.
Methods
A systematic literature review of case reports/series of MDs as irAEs of ICIs was performed.
Results
Of 5682 eligible papers, 26 articles with 28 patients were included. MDs occur as a rare complication of cancer immunotherapy with heterogeneous clinical presentations and in most cases in association with other irAEs. Inflammatory basal ganglia T2/fluid attenuated inversion recovery abnormalities are rarely observed, but brain imaging is frequently unrevealing. Cerebrospinal fluid findings are frequently suggestive of inflammation. Half of cases are associated with a wide range of autoantibodies. Steroids and ICI withdrawal usually lead to improvement, even though some patients experienced relapses or a severe clinical course.
Conclusion
MDs are a rare complication of ICIs that should be promptly recognized to offer patients a correct diagnosis and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
ORCID-Profile: Alessandro Dinoto, Stefano Tamburin, Michele Tinazzi, Sara Mariotto
Zitieren
APA
Dinoto, A., Trentinaglia, M., Carta, S., Mantovani, E., Ferrari, S., Tamburin, S., Tinazzi, M., & Mariotto, S. (2024). Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14003
Vancouver
Dinoto A, Trentinaglia M, Carta S, Mantovani E, Ferrari S, Tamburin S, et al. Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14003
BibTeX
@article{Dinoto2024,
author = {Dinoto, Alessandro and Trentinaglia, Milena and Carta, Sara and Mantovani, Elisa and Ferrari, Sergio and Tamburin, Stefano and Tinazzi, Michele and Mariotto, Sara},
title = {Autoimmune Movement Disorders Complicating Treatment with Immune Checkpoint Inhibitors},
journal = {Movement Disorders Clinical Practice},
year = {2024},
doi = {10.1002/mdc3.14003}
}
EUVIMED